Keyphrases
COVID-19
100%
Melanoma Patients
100%
Northeastern United States
100%
Lockdown
100%
Melanoma Treatment
100%
Melanoma
66%
Adjuvant Therapy
33%
Stage III-IV
33%
Medical Care
16%
Cancer Center
16%
Downstream Effects
16%
Health Care Delivery
16%
In Situ
16%
Retrospective Cohort Study
16%
Colon Cancer
16%
Advanced Disease
16%
Large Volume
16%
Outcome-based
16%
Treatment Delay
16%
Patient Outreach
16%
Medical Screening
16%
Screening for Breast Cancer
16%
Non-urgent Care
16%
Melanoma in Situ
16%
Post-lockdown Period
16%
Medicine and Dentistry
COVID-19
100%
Melanoma
100%
Adjuvant Therapy
28%
Diseases
28%
Medical Care
14%
Breast Cancer
14%
Malignant Neoplasm
14%
Retrospective Cohort Study
14%
Colon Carcinoma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Diseases
28%
Malignant Neoplasm
14%
Breast Cancer
14%
Cohort Study
14%
Colon Carcinoma
14%